Skip to main content
Clinical Trials/NL-OMON22686
NL-OMON22686
Not yet recruiting
Not Applicable

Prognostic value of Fluorine-18 3-deoxy-3-fluorothymidine ([18F]FLT) uptake in resectable liver metastases of colorectal cancer.

Department of Nuclear Medicine & PET Research VU University medical centreP.O. Box 7057, 1007 MB Amsterdam0 sites100 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
-resectable liver metastases of colorectal cancer-operabele levermetastasen van colorectale kanker
Sponsor
Department of Nuclear Medicine & PET Research VU University medical centreP.O. Box 7057, 1007 MB Amsterdam
Enrollment
100
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
Department of Nuclear Medicine & PET Research VU University medical centreP.O. Box 7057, 1007 MB Amsterdam

Eligibility Criteria

Inclusion Criteria

  • 1\. Technically resecrable liver metastases at
  • the time of hepatic recurrence diagnosis;

Exclusion Criteria

  • 1\. Claustrophobia prohibiting PET\-scanning;
  • 2\. Systemic cancer therapy within 3 months
  • prior to PET;

Outcomes

Primary Outcomes

Not specified

Similar Trials